Virios Therapeutics, Inc. (NASDAQ:VIRI) Q3 2023 Earnings Call Transcript November 13, 2023 Virios Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.1. Operator: Good day, and welcome to the Virios Therapeutics, Inc. Third Quarter 2023 Earnings Update. At this time, all participants have been placed on a listen-only mode. Please be advised […]
Related Keywords
, Angela Walsh , Greg Duncan , Care Group , Drug Administration , Bateman Horne Center , Routine Care Group , Vice President , Hot Stocks To Buy Now , Lowest Short , Virios Therapeutics , Nc , Reasurer For Virios Therapeutics Inc , Forward Looking Statements , Long Covid , Fda , Covid ,
comparemela.com © 2020. All Rights Reserved.